top of page
Latest News


Precision Oncology: Emerging Technologies & Implementation
January 12-15, 2025 | Beaver Run Conference Center, Breckenridge, CO, USA Dr. Kyuson Yun, Co-Founder, EMPIRI, Inc.

EMPIRI Inc.
Apr 8, 2025
SFPM 2024 October Virtual Monthly Seminar featuring our co-founder Kyuson Yun, PhD
Join us at this month's virtual seminar as our co-founder Kyuson Yun, PhD will present "E-slice: TME-intact 3D culture platform for functional precision medicine and immunotherapy evaluation" Learn about our proprietary E-slice technology that can preserve a tumor TME for improved precision medicine and immune response. SEMINAR DETAILS Wednesday, October 9, 2024 @ 12:00 PM EDT Meeting URL: zoom.us Meeting ID: 828 5622 5783 | Password: 027718 To learn more, please visit: ...

EMPIRI Inc.
Oct 8, 2024
Join Us at the 10x Genomics User Group Meeting!
We are excited to share that Kyuson Yun, co-founder of Empiri, will be presenting at the 10x Genomics User Group Meeting. This is a fantastic opportunity to learn about our high-quality, end-to-end single cell RNA sequencing services, from tissue dissociation to bioinformatics analysis. Event Details: Date: May 21, 2024 Location: Westin Houston Medical Center, Houston, TX Kyuson’s talk “Elucidating mechanisms of action of a novel immune modulator through single cell RNA-seque

EMPIRI Inc.
May 20, 2024
Our store-front at Scientist.com
EMPIRI's E-slice 3D tumor culture platform for real-time evaluation of therapeutic candidates can now be accessed through our store-front at Scienist.Com for expedited study quoting and contracting. https://app.scientist.com/providers/empiri-inc E-slice enables efficacy, target validation, and MOA studies, including chemo, targeted, immune, virotherapy, cell-based and combinations while maintaining the native TME cell-cell and cell-matrix interactions unique to each patient

EMPIRI Inc.
Mar 9, 2024
bottom of page
